|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2004-5-11
|
|
pubmed:abstractText |
Although anagrelide is widely used in the treatment of thrombocythemia in myeloproliferative diseases, there is currently limited information on the efficacy and toxicity of its long-term use. This prospective study investigated clinical toxicity and efficacy of anagrelide during two years of treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1592-8721
|
|
pubmed:author |
pubmed-author:BirgegårdGunnarG,
pubmed-author:BjörkholmMagnusM,
pubmed-author:KuttiJackJ,
pubmed-author:LärfarsGerdG,
pubmed-author:LöfvenbergEvaE,
pubmed-author:MarkevärnBeritB,
pubmed-author:MauritzsonNilsN,
pubmed-author:MerupMatsM,
pubmed-author:PalmbladJanJ,
pubmed-author:SamuelssonJanJ,
pubmed-author:WestinJanJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
520-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15136214-Adult,
pubmed-meshheading:15136214-Aged,
pubmed-meshheading:15136214-Chronic Disease,
pubmed-meshheading:15136214-Diarrhea,
pubmed-meshheading:15136214-Dose-Response Relationship, Drug,
pubmed-meshheading:15136214-Female,
pubmed-meshheading:15136214-Headache,
pubmed-meshheading:15136214-Heart Rate,
pubmed-meshheading:15136214-Humans,
pubmed-meshheading:15136214-Male,
pubmed-meshheading:15136214-Middle Aged,
pubmed-meshheading:15136214-Myeloproliferative Disorders,
pubmed-meshheading:15136214-Nausea,
pubmed-meshheading:15136214-Patient Compliance,
pubmed-meshheading:15136214-Patient Dropouts,
pubmed-meshheading:15136214-Platelet Aggregation Inhibitors,
pubmed-meshheading:15136214-Prospective Studies,
pubmed-meshheading:15136214-Quinazolines,
pubmed-meshheading:15136214-Thrombocytosis
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.
|
|
pubmed:affiliation |
Dept. Int Medicine, University Hospital, Uppsala, Sweden. Gunnar.Birgegard@medsci.uu.se
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
